This is

Bayer in Canada

Bayer in Canada

In this age of rapid change, we strive to deliver the world’s best solutions to global challenges in the fields of health and nutrition.

With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

In Canada, we have over 1,400 passionate and innovative employees. As a Life Science company we have three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health and Radiology business units.  We are committed to operating sustainably and addressing our social and ethical responsibilities. As we continue to shape our industry, our efforts are catalyzed by focusing on our customers. All of this makes up our corporate purpose: Science for a better life.

News

July 30, 2019

Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion

Read more
July 22, 2019

Yellow Wood Partners to acquire iconic Dr. Scholl’s™ brand from Bayer

Yellow Wood Partners and Bayer announced today that Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 585 million U.S. dollars. Read more
Bayer News Overview